| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |